Peninsula Acquired For $245M; PPI-0903 Destined For Spinout April 20, 2005 In a $245 million cash-for-stock transaction, Ortho-McNeil Pharmaceutical Inc. signed a definitive agreement to acquire Peninsula Pharmaceuticals Inc. and its lead anti-infective compound, doripenem. (BioWorld Today)Read More
RSS